Published in Cancer Weekly, December 12th, 2000
"The pretherapeutic hemoglobin level...has been postulated to constitute a prognostic marker for outcome after primary chemoradiation of patients with advanced cancer of the head and neck," wrote Andreas Dietz and colleagues at the University of Heidelberg in the journal HNO. "However, this hypothesis has not been tested systematically in large study samples."
Dietz et al., therefore, reviewed data from two large multicenter trials involving...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.